Sterling Pharmaceutical Recalled Nine Eye Products
The manufacturer issued a nationwide recall for various eye drops and ointments due to potential sterility issues.
Updated on Sept. 29, 2026 in Consumer Goods
Live Poll
Do you generally trust the safety of over-the-counter eye products sold at major retail stores?
On August 20, 2026, Sterling Pharmaceutical Services initiated a nationwide recall of nine over-the-counter eye drop and ointment products. The FDA classified the recall as Class II, noting the company could not ensure the sterility of the items.
Why it matters
The recall was issued because the manufacturer could not confirm that its production process adequately protected the products from potential contamination. While no injuries have been reported, the action serves as a precaution to prevent health risks associated with non-sterile ophthalmic preparations.
The recall involves nine distinct eye drop and ointment product listings with lot numbers ranging from 3161 to 3336. These items, which feature expiration dates between August 2026 and July 2027, were distributed nationwide.
The players
Sterling Pharmaceutical Services
This is the Illinois-based manufacturing company responsible for the recalled eye care products.
Food and Drug Administration
This is the federal agency that regulates the safety and efficacy of medical products and oversaw the Class II recall classification.
The details
Consumers are urged to check the packaging of products under the Walgreens, AvKare, Reliable-1, TRP, Cameron, and Major brands to determine if they are affected by this recall. The manufacturer identified a lack of assurance regarding the sterility of these specific batches during its production monitoring process.
Timeline
The product recall began on August 20, 2026.
The FDA classified the recall as Class II during the week of September 25, 2026.
The affected items carry expiration dates spanning from August 2026 through July 2027.
Market Landscape
This recall follows a pattern set by the 2023 EzriCare artificial tears recall, which also highlighted systemic sterility concerns in over-the-counter ophthalmic manufacturing. Such actions continue to shift market share as retailers and consumers increasingly prioritize products from manufacturers with verified sterilization protocols.
Customers who purchased eye drops or ointments under the affected brands should verify the lot numbers on their product packaging. Those holding products within the 3161 to 3336 range should discontinue use immediately to avoid potential health complications.
The takeaway
Maintaining product sterility remains a critical safety standard for all over-the-counter ophthalmic manufacturers. Consumers should regularly check official FDA recall databases to ensure any personal care products in their homes remain safe for use.
Further reading
Learn more about safety protocols and industry standards in the Consumer Goods section.
Source note: This article includes information reported by Medical Daily.
Live Poll
Do you generally trust the safety of over-the-counter eye products sold at major retail stores?
